Evaluation of circulating tumor DNA by electropherogram analysis and methylome profiling in high-risk neuroblastomas.

Autor: Trinidad EM; Laboratory of Cellular and Molecular Biology, Health Research Institute Hospital La Fe, Valencia, Spain.; Clinical and Translational Research in Cancer, Health Research Institute Hospital La Fe, Valencia, Spain., Juan-Ribelles A; Clinical and Translational Research in Cancer, Health Research Institute Hospital La Fe, Valencia, Spain.; Pediatric Oncology Unit, La Fe University Hospital, Valencia, Spain., Pisano G; Clinical and Translational Research in Cancer, Health Research Institute Hospital La Fe, Valencia, Spain.; Pediatric Oncology Unit, La Fe University Hospital, Valencia, Spain., Castel V; Clinical and Translational Research in Cancer, Health Research Institute Hospital La Fe, Valencia, Spain.; Pediatric Oncology Unit, La Fe University Hospital, Valencia, Spain., Cañete A; Clinical and Translational Research in Cancer, Health Research Institute Hospital La Fe, Valencia, Spain.; Pediatric Oncology Unit, La Fe University Hospital, Valencia, Spain.; School of Medicine, University of Valencia, Valencia, Spain., Gut M; National Center for Genomic Analysis - Centre for Genomic Regulation (CNAG-CRG), Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Universitat Pompeu Fabra (UPF), Barcelona, Spain., Heath S; National Center for Genomic Analysis - Centre for Genomic Regulation (CNAG-CRG), Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Universitat Pompeu Fabra (UPF), Barcelona, Spain., Font de Mora J; Laboratory of Cellular and Molecular Biology, Health Research Institute Hospital La Fe, Valencia, Spain.; Clinical and Translational Research in Cancer, Health Research Institute Hospital La Fe, Valencia, Spain.

Publikováno v: Frontiers in oncology [Front Oncol] 2023 May 12; Vol. 13, pp. 1037342. Date of Electronic Publication: 2023 May 12 (Print Publication: 2023).

Publisher Correction: Clinical Features of Neuroblastoma With 11q Deletion: An Increase in Relapse Probabilities In Localized And 4S Stages

Autor: Juan Ribelles A, Barberá S, Yáñez Y, Gargallo P, Segura V, Juan B, Noguera R, Piqueras M, Fornés-Ferrer V, Font de Mora J, Cañete A, Castel V

Publikováno v: Scientific Reports
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
SCIENTIFIC REPORTS
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::8daee2c62f16ef7b4c1c9aa822ebe132
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=4520

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Distribution of segmental chromosomal alterations in neuroblastoma.

Autor: Juan Ribelles, A., Gargallo, P., Ferriol, C., Segura, V., Yáñez, Y., Juan, B., Cañada, A. J., Font de Mora, J., Cañete, A., Castel, V.

Publikováno v: Clinical & Translational Oncology; Jun2021, Vol. 23 Issue 6, p1096-1104, 9p

Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1).

Autor: Bellini A; Equipe SiRIC RTOP Recherche Translationelle en Oncologie Pédiatrique, Institut Curie, Paris, France.; INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Institut Curie, Paris, France.; SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France., Pötschger U; Department for Studies and Statistics and Integrated Research, Vienna, Austria.; St Anna Children's Cancer Research Institute, Vienna, Austria., Bernard V; Institut Curie Genomics of Excellence (ICGex) Platform, Research Center, Institut Curie, Paris, France., Lapouble E; Unité de Génétique Somatique, Service de Génétique, Hospital Group, Institut Curie, Paris, France., Baulande S; Institut Curie Genomics of Excellence (ICGex) Platform, Research Center, Institut Curie, Paris, France., Ambros PF; St Anna Children's Cancer Research Institute, Vienna, Austria., Auger N; Service de Génétique des tumeurs; Institut Gustave Roussy, Villejuif, France., Beiske K; Department of Pathology, Oslo University Hospital, and Medical Faculty, University of Oslo, Oslo, Norway., Bernkopf M; St Anna Children's Cancer Research Institute, Vienna, Austria., Betts DR; Department of Clinical Genetics, Children's Health Ireland at Crumlin, Dublin, Ireland., Bhalshankar J; Equipe SiRIC RTOP Recherche Translationelle en Oncologie Pédiatrique, Institut Curie, Paris, France.; INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Institut Curie, Paris, France.; SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France., Bown N; Northern Genetics Service, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom., de Preter K; Ghent University, Ghent, Belgium., Clément N; Equipe SiRIC RTOP Recherche Translationelle en Oncologie Pédiatrique, Institut Curie, Paris, France.; INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Institut Curie, Paris, France.; SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France., Combaret V; Translational Research Laboratory, Centre Léon Bérard, Lyon, France., Font de Mora J; Instituto de Investigación Sanitaria La Fe, Valencia, Spain., George SL; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom., Jiménez I; Equipe SiRIC RTOP Recherche Translationelle en Oncologie Pédiatrique, Institut Curie, Paris, France.; INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Institut Curie, Paris, France.; SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France., Jeison M; Schneider Children's Medical Center of Israel, Tel Aviv University, Tel Aviv, Israel., Marques B; Departamento de Genética Humana, Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisbon, Portugal., Martinsson T; Sahlgrenska University Hospital, Göteborg, Sweden., Mazzocco K; Department of Pathology, IRCCS Istituto Giannina Gaslini, Genova, Italy., Morini M; Laboratory of Molecular Biology, IRCCS Istituto Giannina Gaslini, Genova, Italy., Mühlethaler-Mottet A; Pediatric Hematology-Oncology Research Laboratory, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Noguera R; Department of Pathology, Medical School, University of Valencia-Incliva Health Research Institute/CIBERONC, Madrid, Spain., Pierron G; Unité de Génétique Somatique, Service de Génétique, Hospital Group, Institut Curie, Paris, France., Rossing M; Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Taschner-Mandl S; St Anna Children's Cancer Research Institute, Vienna, Austria., Van Roy N; Ghent University, Ghent, Belgium., Vicha A; Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic., Chesler L; Paediatric Tumour Biology, Division of Clinical Studies, The Institute of Cancer Research, Sutton, United Kingdom., Balwierz W; Department of Pediatric Oncology and Hematology, Institute of Pediatrics, Jagiellonian University Medical College, Krakow, Poland., Castel V; Clinical and Translational Oncology Research Group, Health Research Institute La Fe, Valencia, Spain., Elliott M; Leeds Children's Hospital, Leeds General Infirmary, Leeds, United Kingdom., Kogner P; Karolinska University Hospital, Stockholm, Sweden., Laureys G; Department of Paediatric Haematology and Oncology, Princess Elisabeth Children's Hospital, Ghent University Hospital, Ghent, Belgium., Luksch R; Paediatric Oncology, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy., Malis J; Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic., Popovic-Beck M; Pediatric Hematology-Oncology Unit, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Ash S; Ruth Rappaport Children's Hospital, Rambam Health Care Campus, Haifa, Israel., Delattre O; INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Institut Curie, Paris, France.; SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France.; Institut Curie Genomics of Excellence (ICGex) Platform, Research Center, Institut Curie, Paris, France., Valteau-Couanet D; Département d'Oncologie Pédiatrique, Gustave Roussy, Villejuif, France., Tweddle DA; Wolfson Childhood Cancer Research Centre, Newcastle Centre for Cancer, Translational & Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom., Ladenstein R; Department for Studies and Statistics and Integrated Research, St Anna Children's Hospital, St Anna Children's Cancer Research Institute, Vienna, Austria.; Department of Paediatrics, Medical University of Vienna, Vienna, Austria., Schleiermacher G; Equipe SiRIC RTOP Recherche Translationelle en Oncologie Pédiatrique, Institut Curie, Paris, France.; INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Institut Curie, Paris, France.; SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Oct 20; Vol. 39 (30), pp. 3377-3390. Date of Electronic Publication: 2021 Jun 11.